Mina Nikanjam

Also affiliated with University of California San Diego, Moores Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study”.

Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study

Genome Medicine(2021)10.1186/s13073-021-00969-w

N/A

1.9DataRank · unranked

90 citations

Shumei Kato, Ryosuke Okamura, Hitendra Patel, Mina Nikanjam, Paul T. Fanta +14 more

Tumor mutational burden is not predictive of cytotoxic chemotherapy response

OncoImmunology(2020)10.1080/2162402x.2020.1781997

N/A

0.989DataRank · unranked

17 citations

Paul Riviere, Aaron M. Goodman, Donald A. Barkauskas, Garrett M. Frampton, Razelle Kurzrock +1 more

Review of precision cancer medicine: Evolution of the treatment paradigm

Cancer Treatment Reviews(2020)10.1016/j.ctrv.2020.102019

N/A

0.987DataRank · unranked

720 citations

Elena Fountzilas, Mina Nikanjam, Razelle Kurzrock, Apostolia M. Tsimberidou

ICOS and ICOS ligand: expression patterns and outcomes in oncology patients

Therapeutic Advances in Medical Oncology(2025)10.1177/17588359251330514

N/A

0.343DataRank · unranked

8 citations

Shumei Kato, Daisuke Nishizaki, Donald A. Barkauskas, Sarabjot Pabla, Mary Nesline +4 more

Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics Approach

Clinical Pharmacology & Therapeutics(2020)10.1002/cpt.2026

N/A

0DataRank · unranked

10 citations

Mina Nikanjam, Coleen K. Cunningham, Elizabeth J. McFarland, Emily E. Coates, Katherine V. Houser +10 more

BRAF V600E/V600K Mutations versus Nonstandard Alterations: Prognostic Implications and Therapeutic Outcomes

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0861

N/A

0DataRank · unranked

14 citations

Jose Tinajero, Donald A. Barkauskas, Razelle Kurzrock, Mina Nikanjam

At the right dose: personalised (N-of-1) dosing for precision oncology

European Journal of Cancer(2023)10.1016/j.ejca.2023.113359

N/A

0DataRank · unranked

12 citations

Shumei Kato, Jason K. Sicklick, Razelle Kurzrock, Mina Nikanjam

Brief Report: Dolutegravir Plasma Protein Binding and Unbound Concentrations During Pregnancy and Postpartum

JAIDS Journal of Acquired Immune Deficiency Syndromes(2023)10.1097/qai.0000000000003281

N/A

0DataRank · unranked

6 citations

Mina Nikanjam, Brookie M. Best, Mark Mirochnick, Edmund V. Capparelli, Tim R. Cressey +1 more

Viewing the immune checkpoint VISTA: landscape and outcomes across cancers

ESMO Open(2024)10.1016/j.esmoop.2024.102942

N/A

0DataRank · unranked

31 citations

Razelle Kurzrock, Hirotaka Miyashita, Jacob J. Adashek, Suzanna Lee, Mina Nikanjam +10 more

Reverse repurposing: Potential utility of cancer drugs in nonmalignant illnesses

Med(2024)10.1016/j.medj.2024.04.008

N/A

0DataRank · unranked

7 citations

Kaitlyn Wells, Shumei Kato, Jacob J. Adashek, Shanna Block, Razelle Kurzrock +1 more

Critical insights into the evolving drug‐approval process in China

Cancer(2024)10.1002/cncr.35186

N/A

0DataRank · unranked

0 citations

Razelle Kurzrock, Mina Nikanjam

Nectin-4 expression patterns and therapeutics in oncology

Cancer Letters(2025)10.1016/j.canlet.2025.217681

N/A

0DataRank · unranked

20 citations

Judith Pérez‐Granado, Mark Gramling, Bruno Larvol, Razelle Kurzrock, Mina Nikanjam

Tumour-agnostic kinase inhibitors

Nature Reviews Drug Discovery(2025)10.1038/s41573-025-01147-y

N/A

0DataRank · unranked

14 citations

Mina Nikanjam, Razelle Kurzrock, Jacob J. Adashek

Novel clinical trial designs emerging from the molecular reclassification of cancer

CA A Cancer Journal for Clinicians(2025)10.3322/caac.21880

N/A

0DataRank · unranked

11 citations

Shumei Kato, Teresa Allen, Jason K. Sicklick, Razelle Kurzrock, Mina Nikanjam

Inducible T‐Cell Co‐Stimulator ( ICOS ) and ICOS Ligand: Dealing With a Two‐Faced Cancer Immunoregulatory System

Cancer Medicine(2025)10.1002/cam4.71467

N/A

0DataRank · unranked

5 citations

Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Sarabjot Pabla, Mary Nesline +5 more

Cracking the resistance code: The molecular reclassification of cancer and precision therapy strategies

Seminars in Cancer Biology(2025)10.1016/j.semcancer.2025.10.004

N/A

0DataRank · unranked

3 citations

Razelle Kurzrock, Mina Nikanjam

Model-based assessment of VRC07-523LS dosing in infants through population pharmacokinetic -pharmacodynamic modelling in adults and infants

Journal of Antimicrobial Chemotherapy(2025)10.1093/jac/dkaf449

N/A

0DataRank · unranked

1 citations

Mina Nikanjam, Coleen K. Cunningham, Elizabeth J McFarland, Petronella Muresan, Charlotte Perlowski +7 more

Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy

Nature Communications(2020)10.1038/s41467-020-18613-3

N/A

0DataRank · unranked

303 citations

Ki Hwan Kim, Hyo Jeong Lim, Amélie Boichard, Mina Nikanjam, Elizabeth Weihe +17 more

Expression of TIM3/VISTA checkpoints and the CD68 macrophage-associated marker correlates with anti-PD1/PDL1 resistance: implications of immunogram heterogeneity

OncoImmunology(2020)10.1080/2162402x.2019.1708065

N/A

0DataRank · unranked

68 citations

Ryosuke Okamura, Yuichi Kumaki, Sadakatsu Ikeda, Mina Nikanjam, Ramez N. Eskander +9 more

Relationship between tumor mutational burden and maximum standardized uptake value in 2-[18F]FDG PET (positron emission tomography) scan in cancer patients

EJNMMI Research(2020)10.1186/s13550-020-00732-z

N/A

0DataRank · unranked

14 citations

Donald A. Barkauskas, Matthew Zabel, Aaron M. Goodman, Garrett M. Frampton, Mina Nikanjam +3 more